All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Scorr-Insert

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

A collaboration with SCORR Marketing

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

Halix BV

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Netherlands

Post An Enquiry

BIO International Convention

Participation Not Confirmed

Update your events

HALIX Enters Collaboration with the University of Oxford for GMP Manufacturing of a COVID-19 Vaccine

Contact the Supplier

Lead Product(s): ChAdOx1 nCoV-19

Therapeutic Area: Infections and Infectious Diseases

Highest Development Status: Phase I/ Phase II Product Type: Vaccine

Partner/Sponsor/Collaborator: University’s Jenner Institute

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration April 15, 2020

Details:

Under the collaboration, Halix will utilise its brand new state-of-the-art GMP facilities with capacity up to 1,000 L SUB scale, supporting the manufacture of ChAdOx1 nCoV-19 clinical trial material.